世界のウイルス検体採取市場は、2021年の56億ドルから、2026年までに54億ドルに達し、予測期間中のCAGRは-0.6％と予想されます。この市場の成長を促す主な要因としては、ウイルス性疾患の蔓延、ヒトパピローマウイルス（HPV）と子宮頸がんの蔓延、および献血の増加が挙げられます。
COVID-19パンデミックの出現によって、世界中の医療の提供が一変しました。COVID-19患者の入院率の上昇による圧力が高まったことから、COVID-19患者を治療するための多くの病院や診療科の再プロファイリングが行われました。COVID-19の発生によって世界中で夜間外出禁止令やロックダウンが発出され、献血の停滞、献血運動の減少/キャンセル、献血の需要の減少につながりました。それは、ウイルス検体採取市場の成長に軽度から中程度の影響を及ぼしました。夜間外出禁止令やソーシャルディスタンシングに関する厳格さが緩くなるにつれて、需要が拡大し、市場に不足が生じるでしょう。しかし、世界各国の政府は、ロックダウン後の需要の急増に対応するために、予測期間中、検体採取を増やすための取組みをしています。
さらに、SARS-CoV-2、AIDS、インフルエンザ、エボラ、ジカウイルス、性感染症などのウイルス性疾患の蔓延は、効果的なウイルス検体採取の需要を促す主要な要因です。WHO（2021年7月）によると、2020年末時点で推定3,770万人（3,020〜4,510万人）のHIV感染者がおり、その3分の2以上（2,540万人）がWHOアフリカ地域に住んでいます。2020年には、68万人（48万〜100万人）がHIV関連の原因で死亡し、150万人（100万〜200万人）がHIVに感染しました。さらに、WHO（2021年7月）によると、2020年には世界で推定700万件の新たな梅毒感染がありました。これは、ウイルス検体採取市場の需要をさらに促進すると予想されます。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 13)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 16)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 VIROLOGY SPECIMEN COLLECTION MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 5 VIROLOGY SPECIMEN COLLECTION MARKET: TOP-DOWN APPROACH
2.4 ASSUMPTIONS FOR THE STUDY
2.5 GROWTH RATE ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
2.8 COVID-19 HEALTH ASSESSMENT
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE VIROLOGY SPECIMEN COLLECTION MARKET
3 MARKET OVERVIEW (Page No. - 26)
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
FIGURE 8 VIROLOGY SPECIMEN COLLECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
3.2.1 DRIVERS
3.2.1.1 Rising prevalence of viral diseases and emergence of newer pathogens
3.2.1.2 Rising number of blood donations
3.2.2 RESTRAINTS
3.2.2.1 Need for alternative technologies
3.2.3 OPPORTUNITIES
3.2.3.1 Technological advancements
3.2.3.2 Lucrative opportunities in emerging economies
3.2.4 CHALLENGES
3.2.4.1 High cost of technologies and collection kits
3.2.4.2 Usage of low-sensitivity screening
3.3 IMPACT OF COVID-19 ON THE VIROLOGY SPECIMEN COLLECTION MARKET
3.4 PESSIMISTIC, OPTIMISTIC, AND REALISTIC SCENARIOS
3.4.1 VIROLOGY SPECIMEN COLLECTION MARKET
FIGURE 9 PESSIMISTIC SCENARIO
FIGURE 10 OPTIMISTIC SCENARIO
FIGURE 11 REALISTIC SCENARIO
3.5 PRICING ANALYSIS
TABLE 1 PRICE OF VIROLOGY SPECIMEN COLLECTION PRODUCTS (2021)
3.6 PATENT ANALYSIS
3.6.1 PATENT ANALYSIS OF VIRAL TRANSPORT MEDIA
3.6.2 PATENT ANALYSIS OF BLOOD COLLECTION KITS
3.7 TRADE ANALYSIS
3.7.1 TRADE ANALYSIS FOR DIAGNOSTIC REAGENTS
TABLE 2 IMPORT DATA FOR PREPARED CULTURE MEDIA FOR THE DEVELOPMENT OR MAINTENANCE OF MICRO-ORGANISMS INCL. VIRUSES AND THE LIKE OR OF PLANT, HUMAN OR ANIMAL CELLS, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 3 EXPORT DATA FOR PREPARED CULTURE MEDIA FOR THE DEVELOPMENT OR MAINTENANCE OF MICRO-ORGANISMS INCL. VIRUSES AND THE LIKE OR OF PLANT, HUMAN OR ANIMAL CELLS, BY COUNTRY, 2016-2020 (USD MILLION)
3.8 VALUE CHAIN ANALYSIS
FIGURE 12 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
3.9 SUPPLY CHAIN ANALYSIS
FIGURE 13 VIROLOGY SPECIMEN COLLECTION MARKET: SUPPLY CHAIN ANALYSIS
3.10 ECOSYSTEM ANALYSIS OF THE VIROLOGY SPECIMEN COLLECTION MARKET
FIGURE 14 VIROLOGY SPECIMEN COLLECTION MARKET: ECOSYSTEM ANALYSIS
3.10.1 ROLE IN ECOSYSTEM
3.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 VIROLOGY SPECIMEN COLLECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
3.11.1 THREAT OF NEW ENTRANTS
3.11.2 THREAT OF SUBSTITUTES
3.11.3 BARGAINING POWER OF BUYERS
3.11.4 BARGAINING POWER OF SUPPLIERS
3.11.5 DEGREE OF COMPETITION
3.12 REGULATORY LANDSCAPE
3.12.1 NORTH AMERICA
3.12.1.1 US
3.12.1.2 Canada
3.12.2 EUROPE
3.12.3 ASIA PACIFIC
3.12.3.1 Japan
3.12.3.2 India
3.12.4 LATIN AMERICA
3.12.4.1 Brazil
3.12.4.2 Mexico
3.12.5 MIDDLE EAST
3.13 CASE STUDY ANALYSIS
3.13.1 CASE STUDY 1
3.14 TECHNOLOGY ANALYSIS
3.15 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS
3.15.1 REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC
3.15.2 REVENUE SHIFT FOR THE VIROLOGY SPECIMEN COLLECTION MARKET
4 VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE (Page No. - 44)
4.1 INTRODUCTION
TABLE 5 VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019-2026 (USD MILLION)
4.2 VIRAL TRANSPORT MEDIA
4.2.1 REPEAT PURCHASE OF VIRAL TRANSPORT MEDIA TO DRIVE MARKET GROWTH IN THE COMING YEARS
TABLE 6 VIROLOGY SPECIMEN COLLECTION MARKET FOR VIRAL TRANSPORT MEDIA, BY REGION, 2019-2026 (USD MILLION)
4.3 SPECIMEN COLLECTION TUBES
4.3.1 SURGE IN PATIENT POPULATION TO DRIVE SEGMENT GROWTH
TABLE 7 VIROLOGY SPECIMEN COLLECTION MARKET FOR SPECIMEN COLLECTION TUBES, BY REGION, 2019-2026 (USD MILLION)
4.4 SWABS
4.4.1 INCREASING INCIDENCE OF VIRAL DISEASES TO PROPEL MARKET GROWTH
TABLE 8 VIROLOGY SPECIMEN COLLECTION MARKET FOR SWABS, BY REGION, 2019-2026 (USD MILLION)
4.5 BLOOD COLLECTION KITS
4.5.1 GROWING PRESSURE ON CLINICAL LABORATORIES TO DRIVE THE MARKET GROWTH
TABLE 9 VIROLOGY SPECIMEN COLLECTION MARKET FOR BLOOD COLLECTION KITS, BY REGION, 2019-2026 (USD MILLION)
5 VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE (Page No. - 49)
5.1 INTRODUCTION
TABLE 10 VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019-2026 (USD MILLION)
5.2 BLOOD SAMPLES
5.2.1 RISING NUMBER OF LEUKEMIA AND LYMPHOMA CASES WILL SUPPORT THE MARKET GROWTH
TABLE 11 VIROLOGY SPECIMEN COLLECTION MARKET FOR BLOOD SAMPLES, BY REGION, 2019-2026 (USD MILLION)
5.3 CERVICAL SAMPLES
5.3.1 INCREASING INCIDENCE OF HPV WILL DRIVE THE GROWTH OF THIS SEGMENT
TABLE 12 VIROLOGY SPECIMEN COLLECTION MARKET FOR CERVICAL SAMPLES, BY REGION, 2019-2026 (USD MILLION)
5.4 NASAL SAMPLES
5.4.1 RISING PREVALENCE OF RESPIRATORY DISORDERS TO SUPPORT THE MARKET GROWTH
TABLE 13 VIROLOGY SPECIMEN COLLECTION MARKET FOR NASAL SAMPLES, BY REGION, 2019-2026 (USD MILLION)
5.5 NASOPHARYNGEAL SAMPLES
5.5.1 INCREASE IN NUMBER OF RT-PCR TESTS WILL DRIVE THE GROWTH OF THIS SEGMENT
TABLE 14 VIROLOGY SPECIMEN COLLECTION MARKET FOR NASOPHARYNGEAL SAMPLES, BY REGION, 2019-2026 (USD MILLION)
5.6 THROAT SAMPLES
5.6.1 INCREASING PREVALENCE OF VIRAL DISEASES TO DRIVE THE SEGMENT GROWTH
TABLE 15 VIROLOGY SPECIMEN COLLECTION MARKET FOR THROAT SAMPLES, BY REGION, 2019-2026 (USD MILLION)
5.7 ORAL SAMPLES
5.7.1 QUICK DIAGNOSTIC RESULTS THROUGH ORAL SWABS TO DRIVE THE GROWTH OF THIS MARKET
TABLE 16 VIROLOGY SPECIMEN COLLECTION MARKET FOR ORAL SAMPLES, BY REGION, 2019-2026 (USD MILLION)
5.8 OTHER SAMPLES
TABLE 17 VIROLOGY SPECIMEN COLLECTION MARKET FOR OTHER SAMPLES, BY REGION, 2019-2026 (USD MILLION)
6 VIROLOGY SPECIMEN COLLECTION MARKET, BY REGION (Page No. - 56)
6.1 INTRODUCTION
TABLE 18 VIROLOGY SPECIMEN COLLECTION MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2 NORTH AMERICA
6.2.1 RISING PREVALENCE OF HIV IN THE REGION WILL SUPPORT THE MARKET GROWTH
FIGURE 15 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET SNAPSHOT
TABLE 19 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019-2026 (USD MILLION)
TABLE 20 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019-2026 (USD MILLION)
6.3 EUROPE
6.3.1 RISING INCIDENCE OF HUMAN PAPILLOMAVIRUS TO SUPPORT GROWTH
TABLE 21 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019-2026 (USD MILLION)
TABLE 22 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019-2026 (USD MILLION)
6.4 ASIA PACIFIC
6.4.1 APAC MARKET IS MAINLY DRIVEN BY LARGE-SCALE COVID TESTING ACTIVITY
FIGURE 16 ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET SNAPSHOT
TABLE 23 ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019-2026 (USD MILLION)
TABLE 24 ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019-2026 (USD MILLION)
6.5 REST OF THE WORLD
TABLE 25 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019-2026 (USD MILLION)
TABLE 26 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019-2026 (USD MILLION)
7 COMPANY PROFILES (Page No. - 65)
7.1 KEY PLAYERS
7.1.1 BECTON, DICKINSON AND COMPANY
7.1.2 QUIDEL CORPORATION
7.1.3 THERMO FISHER SCIENTIFIC, INC.
7.1.4 TRINITY BIOTECH
7.1.5 TITAN BIOTECH LTD.
7.1.6 DIASORIN SA
7.1.7 VIRCELL S.L.
7.1.8 COPAN ITALIA S.P.A
7.1.9 PURITAN MEDICAL PRODUCTS CO.
7.1.10 HARDY DIAGNOSTICS
8 APPENDIX (Page No. - 73)
8.1 INSIGHTS FROM INDUSTRY EXPERTS
8.2 DISCUSSION GUIDE
8.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
8.4 AVAILABLE CUSTOMIZATIONS
8.5 AUTHOR DETAILS
